Stratos Wealth Partners LTD. Purchases 2,080 Shares of Astera Labs, Inc. $ALAB

Stratos Wealth Partners LTD. lifted its position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 8.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,403 shares of the company's stock after acquiring an additional 2,080 shares during the quarter. Stratos Wealth Partners LTD.'s holdings in Astera Labs were worth $2,297,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Fred Alger Management LLC lifted its holdings in shares of Astera Labs by 13.0% in the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after acquiring an additional 179,638 shares during the last quarter. Hoey Investments Inc. lifted its holdings in shares of Astera Labs by 22.4% in the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company's stock worth $553,000 after acquiring an additional 1,121 shares during the last quarter. Wealth Effects LLC bought a new stake in shares of Astera Labs in the 2nd quarter worth about $242,000. Maryland State Retirement & Pension System lifted its holdings in shares of Astera Labs by 37.7% in the 2nd quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company's stock worth $629,000 after acquiring an additional 1,906 shares during the last quarter. Finally, Realta Investment Advisors bought a new stake in Astera Labs during the 2nd quarter valued at about $214,000. Institutional investors own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Astera Labs from $160.00 to $200.00 and gave the company a "buy" rating in a report on Tuesday, September 2nd. Susquehanna lifted their price objective on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a report on Thursday, August 7th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Astera Labs in a report on Wednesday, October 8th. Zacks Research lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, October 6th. Finally, TD Cowen started coverage on shares of Astera Labs in a research report on Wednesday, October 1st. They set a "hold" rating and a $200.00 target price on the stock. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $162.06.

Astera Labs Stock Down 2.3%

Shares of Astera Labs stock opened at $159.80 on Monday. The firm's 50 day moving average price is $199.68 and its 200-day moving average price is $128.80. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The company has a market cap of $26.56 billion, a P/E ratio of 285.36, a PEG ratio of 3.98 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same quarter in the previous year, the firm earned $0.13 EPS. The company's quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other news, CEO Jitendra Mohan sold 152,517 shares of Astera Labs stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total value of $25,978,220.61. Following the transaction, the chief executive officer owned 450,001 shares of the company's stock, valued at $76,648,670.33. The trade was a 25.31% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the transaction, the director directly owned 385,863 shares in the company, valued at approximately $66,858,482.01. The trade was a 32.17% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,092,997 shares of company stock worth $192,231,120. 12.50% of the stock is owned by corporate insiders.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.